ADC Therapeutics is a biotechnology company that specializes in the development of highly potent and targeted antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. They use the latest-generation pyrrolobenzodiazepine (PBD) dimer technology to develop their ADCs, which have a superior therapeutic index compared to first-generation PBD ADCs. The company has spe...